Chiang P H, Tsai E M, Chiang C P
Department of Urology, Kaohsiung Medical College, Taiwan, Republic of China.
Gaoxiong Yi Xue Ke Xue Za Zhi. 1994 Jun;10(6):287-94.
The effects of trazodone on the nocturnal penile erection were demonstrated in 14 impotent patients by Rigiscan recordings. Trazodone significantly increased the total erectile time, per cent of sleep with erection and maximum rigidity, while it had no effect on increment of tumescence size. Trazodone (150 mg to 200 mg) was administered to 35 clearly organic impotent patients in a 5-week single-blind design. Patients were evaluated by questionnaire. The study showed an improvement in 68.6 per cent of the patients receiving trazodone versus 11.4 per cent receiving placebo. In vitro, trazodone could relax rabbit corporeal smooth muscle contractions induced by exogenous norepinephrine and inhibit contractions elicited by transmural electrical stimulation of adrenergic nerve endings. The effects of trazodone on penile erection may be due to a peripheral alpha adrenoceptor antagonism and central unknown mechanism. We conclude that trazodone may prove an effective treatment for impotent patients.
通过Rigiscan记录在14例阳痿患者中证实了曲唑酮对夜间阴茎勃起的影响。曲唑酮显著增加了总的勃起时间、勃起睡眠百分比和最大硬度,而对肿胀大小的增加没有影响。采用5周单盲设计,对35例明确为器质性阳痿的患者给予曲唑酮(150毫克至200毫克)。通过问卷调查对患者进行评估。研究表明,接受曲唑酮治疗的患者中有68.6%病情改善,而接受安慰剂治疗的患者中这一比例为11.4%。在体外,曲唑酮可以松弛由外源性去甲肾上腺素诱导的兔海绵体平滑肌收缩,并抑制由肾上腺素能神经末梢经壁电刺激引起的收缩。曲唑酮对阴茎勃起的作用可能归因于外周α肾上腺素能受体拮抗作用和中枢未知机制。我们得出结论,曲唑酮可能被证明是治疗阳痿患者的有效药物。